Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Abstract P6-05-43: Validity of EQ-5D-5L for women with breast cancer

Sofia Torres, Maureen Trudeau, Geoffrey Liu, Nicholas Mitsakakis, Ahmed Bayoumi

Cancer Res (2023) 83 (5_Supplement): P6-05-43.

https://doi.org/10.1158/1538-7445.SABCS22-P6-05-43

Published: 01 March 2023

View article titled, Abstract P6-05-43: Validity of EQ-5D-5L for women with breast cancer

Journal Articles

Abstract PD6-05: PD6-05 Retrospective analysis of VES-13 questionnaires in the Senior Women’s Breast Cancer Clinic at Sunnybrook Health Sciences, Toronto, Ontario, Canada

Ewa F. Szumacher, Arman Zereshkian, Benazir Mir Khan Benazir khan, Xingshan Cao, Nayanee Henry=Noel, Ines Menjak, Rajin Mehta, Bonnie Bristow, Maureen Trudeau, Matthiew Neve, Mirelle Norris, Mark Pasetka, Katie Rice, Fiona McCullock, Frances Wright, Krista Dawdy

Cancer Res (2023) 83 (5_Supplement): PD6-05.

https://doi.org/10.1158/1538-7445.SABCS22-PD6-05

Published: 01 March 2023

View article titled, Abstract PD6-05: PD6-05 Retrospective analysis of VES-13 questionnaires in the Senior Women’s Breast Cancer Clinic at Sunnybrook Health Sciences, Toronto, Ontario, Canada

Journal Articles

Abstract P5-14-11: Retrospective analysis of VES13 questionnaire prior oncology consultation in the Senior Women’s Breast Cancer Clinic at tertiary care center, what have we learned?

Benazir Mir Khan, Arman Zereshkian, Xingshan Cao, Rajin Mehta, Bonnie Bristow, Maureen Trudeau, Nayanee Henry-Noel, Matthew Neve, Mireille Norris, Mark Pasetka, Katie Rice, Fiona McCullock, Frances Wright, Ines Menjak, Ewa Szumacher

Cancer Res (2022) 82 (4_Supplement): P5-14-11.

https://doi.org/10.1158/1538-7445.SABCS21-P5-14-11

Published: 15 February 2022

View article titled, Abstract P5-14-11: Retrospective analysis of VES13 questionnaire prior oncology consultation in the Senior Women’s Breast Cancer Clinic at tertiary care center, what have we learned?

Journal Articles

Abstract P5-18-02: Final findings from the CONTROL trial of diarrheal prophylaxis or neratinib dose escalation on neratinib-associated diarrhea and tolerability in patients with HER2+ early-stage breast cancer

Arlene Chan, Manuel Ruiz-Borrego, Gavin Marx, Adam Brufsky, Jo Chien, Michael Thirlwell, Maureen Trudeau, Ron Bose, José A García-Sáenz, Daniel Egle, Barbara Pistilli, Johanna Wassermann, Kerry A Cheong, Christian F Singer, Daniel Hunt, Navid Foruzan, Leanne McCulloch, Carlos H Barcenas

Cancer Res (2022) 82 (4_Supplement): P5-18-02.

https://doi.org/10.1158/1538-7445.SABCS21-P5-18-02

Published: 15 February 2022

View article titled, Abstract P5-18-02: Final findings from the CONTROL trial of diarrheal prophylaxis or neratinib dose escalation on neratinib-associated diarrhea and tolerability in patients with HER2+ early-stage breast cancer

Journal Articles

Abstract OT2-03-01: RNA disruption assay (RDA) - Breast cancer response evaluation for individualized therapy (brevity/brevity-02)

Maureen Trudeau, Joke Tio, Foluso Ademuyiwa, Thierry Petit, Bryan Hennessy, Marina Cazzaniga, Daniele Generali

Cancer Res (2022) 82 (4_Supplement): OT2-03-01.

https://doi.org/10.1158/1538-7445.SABCS21-OT2-03-01

Published: 15 February 2022

View article titled, Abstract OT2-03-01: RNA disruption assay (RDA) - Breast cancer response evaluation for individualized therapy (brevity/brevity-02)

Journal Articles

Abstract P4-10-22: Patient reported symptoms and functional status in breast cancer

Sofia Torres, Ahmed Bayoumi, Geoffrey Liu, Ana Beatriz Kinupe Abrahao, Nicholas Mitsakakis, Murray Krahn, Maureen Trudeau

Cancer Res (2022) 82 (4_Supplement): P4-10-22.

https://doi.org/10.1158/1538-7445.SABCS21-P4-10-22

Published: 15 February 2022

View article titled, Abstract P4-10-22: Patient reported symptoms and functional status in breast cancer

Journal Articles

Abstract P4-12-11: Eq-5d-5l utility scores for patients with breast cancer

Sofia Torres, Ahmed Bayoumi, Maureen Trudeau, Ana Beatriz Kinupe Abrahao, Nicholas Mitsakakis, Murray Krahn, Geoffrey Liu

Cancer Res (2022) 82 (4_Supplement): P4-12-11.

https://doi.org/10.1158/1538-7445.SABCS21-P4-12-11

Published: 15 February 2022

View article titled, Abstract P4-12-11: Eq-5d-5l utility scores for patients with breast cancer

Journal Articles

Abstract PS10-33: Analysis of factors associated with pathological complete response (pCR) in patients with HER2+ breast cancer receiving neoadjuvant chemotherapy

Neda Stjepanovic, Katarzyna Jerzak, Maureen Trudeau, Andrea Eisen, Sonal Gandhi, Ellen Warner, Danilo Giffoni MM Mata, Anthony Lott, Maria Romero, Sharon Lemon-Wong, Althea VanMassop, Xingshan Cao, William Tran, Rossanna Pezo

Cancer Res (2021) 81 (4_Supplement): PS10-33.

https://doi.org/10.1158/1538-7445.SABCS20-PS10-33

Published: 15 February 2021

View article titled, Abstract PS10-33: Analysis of factors associated with pathological complete response (pCR) in patients with HER2+ breast cancer receiving neoadjuvant chemotherapy

Journal Articles

Abstract PS11-20: Radiation therapy (RT) induced toxicity in advanced breast cancer (ABC) patients treated with CDK4/6 inhibitors (CDK4/6is)

Neda Stjepanovic, Alia Thawer, Dilshad Nathoo, Danilo Giffoni, Maria Romero, Anthony Lott, Andrea Eisen, Rossanna Pezo, Katarzyna Jerzak, Maureen Trudeau, Sonal Gandhi, Ellen Warner

Cancer Res (2021) 81 (4_Supplement): PS11-20.

https://doi.org/10.1158/1538-7445.SABCS20-PS11-20

Published: 15 February 2021

View article titled, Abstract PS11-20: Radiation therapy (RT) induced toxicity in advanced breast cancer (ABC) patients treated with CDK4/6 inhibitors (CDK4/6is)

Journal Articles

Abstract PS13-20: Bringing diarrhea under CONTROL: Dose escalation reduces neratinib-associated diarrhea and improves tolerability in HER2-positive early-stage breast cancer

Manuel Ruiz-Borrego, Arlene Chan, Gavin Marx, Adam Brufsky, A Jo Chien, Michael Thirlwell, Maureen Trudeau, Ron Bose, José A García-Sáenz, Daniel Egle, Daniel Hunt, Utpal Khambholja, Leanne McCulloch, Naisargee Shah, Debu Tripathy, Carlos H Barcenas, the CONTROL Investigators

Cancer Res (2021) 81 (4_Supplement): PS13-20.

https://doi.org/10.1158/1538-7445.SABCS20-PS13-20

Published: 15 February 2021

View article titled, Abstract PS13-20: Bringing diarrhea under CONTROL: Dose escalation reduces neratinib-associated diarrhea and improves tolerability in HER2-positive early-stage breast cancer

Journal Articles

Abstract PD13-09: Impact of neratinib on outcomes in HER2-positive metastatic breast cancer patients with central nervous system disease at baseline: Findings from the phase 3 NALA trial

Cristina Saura, Larisa Ryvo, Sara Hurvitz, William Gradishar, Beverly Moy, Suzette Delaloge, Sung-Bae Kim, Mafalda Oliveira, Maureen Trudeau, Ming-Shen Dai, Barbara Haley, Ron Bose, Luciana Landeiro, Judith Bebchuk, Aimee Frazier, Kiana Keyvanjah, Richard Bryce, Adam Brufsky

Cancer Res (2021) 81 (4_Supplement): PD13-09.

https://doi.org/10.1158/1538-7445.SABCS20-PD13-09

Published: 15 February 2021

View article titled, Abstract PD13-09: Impact of neratinib on outcomes in HER2-positive metastatic breast cancer patients with central nervous system disease at baseline: Findings from the phase 3 NALA trial

Journal Articles

Abstract PS10-54: Single-centre retrospective study of treatment choices and outcomes of metastatic breast cancer post-progression on the CDK4/6 inhibitor palbobiclib

Maria Luisa Romero Lagunes, Faisal Sickandar, Alia Thawer, Neda Stjepanovic, Katarzyna Jerzak, Maureen Trudeau, Andrea Eisen, Sonal Gandhi, Ellen Warner, Danilo Giffoni M. M. Mata, Abdullah MA Al-Humiqani, Anthony Lott, Rossanna C Pezo

Cancer Res (2021) 81 (4_Supplement): PS10-54.

https://doi.org/10.1158/1538-7445.SABCS20-PS10-54

Published: 15 February 2021

View article titled, Abstract PS10-54: Single-centre retrospective study of treatment choices and outcomes of metastatic breast cancer post-progression on the CDK4/6 inhibitor palbobiclib

Journal Articles

Abstract OT-09-04: Analysis of genomic alterations in cell free DNA and gut bacterial diversity in metastatic breast cancer (MBC) patients on endocrine therapy: A pilot study

Rossanna C. Pezo, Andrea Eisen, Sonal Gandhi, Ellen Warner, Katarzyna Jerzak, Maureen Trudeau, Arun Seth

Cancer Res (2021) 81 (4_Supplement): OT-09-04.

https://doi.org/10.1158/1538-7445.SABCS20-OT-09-04

Published: 15 February 2021

View article titled, Abstract OT-09-04: Analysis of genomic alterations in cell free DNA and gut bacterial diversity in metastatic breast cancer (MBC) patients on endocrine therapy: A pilot study

Journal Articles

Abstract P4-01-12: The association of circulating tumor cells with tumor response in breast cancer patients undergoing neoadjuvant chemotherapy

Jacques Raphael, Reza Mohamadi, Alex Kiss, Maureen Trudeau, Sunil Verma, Alison Allan, Shana Kelley, Joelle Helou, Fang-I Lu, Siqi Zhu, Kathleen I Pritchard

Cancer Res (2020) 80 (4_Supplement): P4-01-12.

https://doi.org/10.1158/1538-7445.SABCS19-P4-01-12

Published: 15 February 2020

View article titled, Abstract P4-01-12: The association of circulating tumor cells with tumor response in breast cancer patients undergoing neoadjuvant chemotherapy

Journal Articles

Abstract P5-08-08: Risk reducing mastectomy in average and high risk patients with locally advanced triple negative breast cancer

Neda Stjepanovic, Danilo Giffoni, Sonal Gandhi, Katarzyna Jerzak, Sharon Lemon, Karen Ott, Rossanna Pezo, Kathleen Pritchard, Samuel Tabbarah, Maureen Trudeau, Ellen Warner, William Tran, Andrea Eisen

Cancer Res (2020) 80 (4_Supplement): P5-08-08.

https://doi.org/10.1158/1538-7445.SABCS19-P5-08-08

Published: 15 February 2020

View article titled, Abstract P5-08-08: Risk reducing mastectomy in average and high risk patients with locally advanced triple negative breast cancer

Journal Articles

Abstract CT317: Quantitative ultrasound for personalized chemotherapy in locally advanced breast cancer: Clinical trial results

Gregory Jan Czarnota, Ali Sadeghi-Naini, Hadi Tadayyon, Lakshmanan Sannachi, Mehrdad Gangeh, William Tran, Frances Wright, Sonal Gandhi, Kathleen Pritchard, Sunil Verma, Maureen Trudeau

Cancer Res (2015) 75 (15_Supplement): CT317.

https://doi.org/10.1158/1538-7445.AM2015-CT317

Published: 01 August 2015

View article titled, Abstract CT317: Quantitative ultrasound for personalized chemotherapy in locally advanced breast cancer: Clinical trial results

Journal Articles

Abstract P5-19-09: Preliminary results from a phase 2 single-arm study of enzalutamide, an androgen receptor (AR) inhibitor, in advanced AR+ triple-negative breast cancer (TNBC)

Tiffany A Traina, Joyce O'Shaughnessy, Rita Nanda, Lee Schwartzberg, Vandana Abramson, Javier Cortes, Amy Peterson, Iulia Cristina Tudor, Martha Blaney, Joyce L Steinberg, Catherine Kelly, Maureen Trudeau, Ahmad Awada, Eric Winer, Clifford Hudis, Peter Schmid, Denise A Yardley

Cancer Res (2015) 75 (9_Supplement): P5-19-09.

https://doi.org/10.1158/1538-7445.SABCS14-P5-19-09

Published: 01 May 2015

View article titled, Abstract P5-19-09: Preliminary results from a phase 2 single-arm study of enzalutamide, an androgen receptor (AR) inhibitor, in advanced AR+ triple-negative breast cancer (TNBC)

Journal Articles

Frequency of the CHEK2 1100delC Mutation among Women with Breast Cancer: An International Study

Cancer Res (2008) 68 (7): 2154–2157.

https://doi.org/10.1158/0008-5472.CAN-07-5187

Published: 01 April 2008

View article titled, Frequency of the <em>CHEK2</em> 1100delC Mutation among Women with Breast Cancer: An International Study

NARROW

Abstract P6-05-43: Validity of EQ-5D-5L for women with breast cancer

Abstract PD6-05: PD6-05 Retrospective analysis of VES-13 questionnaires in the Senior Women’s Breast Cancer Clinic at Sunnybrook Health Sciences, Toronto, Ontario, Canada

Abstract P5-14-11: Retrospective analysis of VES13 questionnaire prior oncology consultation in the Senior Women’s Breast Cancer Clinic at tertiary care center, what have we learned?

Abstract P5-18-02: Final findings from the CONTROL trial of diarrheal prophylaxis or neratinib dose escalation on neratinib-associated diarrhea and tolerability in patients with HER2+ early-stage breast cancer

Abstract OT2-03-01: RNA disruption assay (RDA) - Breast cancer response evaluation for individualized therapy (brevity/brevity-02)

Abstract P4-10-22: Patient reported symptoms and functional status in breast cancer

Abstract P4-12-11: Eq-5d-5l utility scores for patients with breast cancer

Abstract PS10-33: Analysis of factors associated with pathological complete response (pCR) in patients with HER2+ breast cancer receiving neoadjuvant chemotherapy

Abstract PS11-20: Radiation therapy (RT) induced toxicity in advanced breast cancer (ABC) patients treated with CDK4/6 inhibitors (CDK4/6is)

Abstract PS13-20: Bringing diarrhea under CONTROL: Dose escalation reduces neratinib-associated diarrhea and improves tolerability in HER2-positive early-stage breast cancer

Abstract PD13-09: Impact of neratinib on outcomes in HER2-positive metastatic breast cancer patients with central nervous system disease at baseline: Findings from the phase 3 NALA trial

Abstract PS10-54: Single-centre retrospective study of treatment choices and outcomes of metastatic breast cancer post-progression on the CDK4/6 inhibitor palbobiclib

Abstract OT-09-04: Analysis of genomic alterations in cell free DNA and gut bacterial diversity in metastatic breast cancer (MBC) patients on endocrine therapy: A pilot study

Abstract P4-01-12: The association of circulating tumor cells with tumor response in breast cancer patients undergoing neoadjuvant chemotherapy

Abstract P5-08-08: Risk reducing mastectomy in average and high risk patients with locally advanced triple negative breast cancer

Abstract CT317: Quantitative ultrasound for personalized chemotherapy in locally advanced breast cancer: Clinical trial results

Abstract P5-19-09: Preliminary results from a phase 2 single-arm study of enzalutamide, an androgen receptor (AR) inhibitor, in advanced AR+ triple-negative breast cancer (TNBC)

Frequency of the CHEK2 1100delC Mutation among Women with Breast Cancer: An International Study

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only